Dual–target platinum(IV) complexes reverse cisplatin resistance in triple negative breast via inhibiting poly(ADP–ribose) polymerase (PARP–1) and enhancing DNA damage-Reference-Cited by-同舟云学术

Dual–target platinum(IV) complexes reverse cisplatin resistance in triple negative breast via inhibiting poly(ADP–ribose) polymerase (PARP–1) and enhancing DNA damage

Published:2023-04 Issue: Volume:133 Page:106354
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Li Rui,Zhao Weiheng,Jin Chen,Xiong Huihua

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference37 articles.

1. Structure–activity relationships of triple–action platinum(IV) prodrugs with albumin–binding properties and immunomodulating ligands;Fronik;J. Med. Chem.,2021

2. Platinum(IV)–estramustine multiaction prodrugs are effective antiproliferative agents against prostate cancer cells;Karmakar;J. Med. Chem.,2020

3. Absence of activation of DNA repair genes and excellent efficacy of phosphaplatins against human ovarian cancers: Implications to treat resistant cancers;Bose;J. Med. Chem.,2015

4. Ketoprofen and loxoprofen platinum(IV) complexes displaying antimetastatic activities by inducing DNA damage, inflammation suppression, and enhanced Immune response;Li;J. Med. Chem.,2021

5. Glycosylated platinum(IV) complexes as substrates for glucose transporters (GLUTs) and organic cation transporters (OCTs) exhibited cancer targeting and human serum albumin binding properties for drug delivery;Ma;J. Med. Chem.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance;Journal of Medicinal Chemistry;2024-05-10

2. Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound;ACS Pharmacology & Translational Science;2024-04-05

3. Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance;Journal of Medicinal Chemistry;2024-04-04

4. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity;Topics in Current Chemistry;2024-02-24

5. Beyond cisplatin: New frontiers in metallodrugs for hard-to-treat triple negative breast cancer;Coordination Chemistry Reviews;2024-01